Invest in the algorithm that will change biotechnology forever.
SynapseAI is building a platform for tokenizing and AI-analyzing scientific assets. We are raising a seed round to launch and scale the project. This is a chance to enter the DeSci market at its inception.
Market Opportunity
The biotech funding market ($2.5T) is inefficient and closed to most investors. We use Web3 and AI to create a new, more liquid and transparent market.
Problem: Locked Capital and High Barriers
Breakthrough scientific developments require huge investments but suffer from illiquidity (capital frozen for 5-10 years) and information asymmetry. This makes the market accessible only to elite funds.
Our Solution: Infrastructure for Growth
- RWA Tokenization: We turn future royalties from patents into liquid digital assets (IP-tokens) on the BNB Chain, opening access to retail and institutional investors.
- AI Scoring: Our AI "Prometheus" analyzes risks, potential, and scientific validity of projects, providing unprecedented transparency.
- Open Marketplace: We are creating a decentralized marketplace where scientists get funding directly, and investors get diversified access to a new asset class (DeSci).
Sustainable Business Model
Our model aims to create a sustainable ecosystem with multiple revenue streams that will grow with the platform's volume and asset liquidity.
Fundraising Commission
We will charge a small commission (2-4%) on successfully funded scientific projects and royalty pools on the platform.
Premium Analytics
Providing premium access to in-depth analytical and due diligence reports from our AI "Prometheus" for institutional funds.
Native Token Economy
Launching a native token for platform governance (DAO), staking, and liquidity provision, which will create circular value.
Infrastructure Services
Providing infrastructure for third-party projects (Launchpad as a Service) wishing to launch their DeSci initiatives on our platform.
Use of Funds
Your capital is the fuel that will turn our technological foundation and vision into a working product ready to change the DeSci market. The seed round funds will be allocated to the following key objectives.
MVP Development & Launch
Completing platform development, including smart contracts, the RWA bridge, and the "Prometheus" AI core.
Legal Structure
Establishing a robust legal framework for RWA operations in key jurisdictions to protect investors.
Team Expansion
Recruiting top specialists in Web3, law, and biotechnology.
Security Audit
Conducting a full audit of smart contracts and infrastructure with a leading cybersecurity firm.
Marketing & GR
Initial marketing campaign to attract pilot projects and build relationships with regulators.
Pilot Partnerships
Securing partnerships with the first scientific projects and universities for the platform's pilot launch.
Roadmap
Your investment will enable us to achieve the following key milestones, ensuring a rapid market entry and scaling.
Phase 1: Foundation (0-6 mos.)
- Finalize development and training of the "Prometheus" AI model V1.
- Establish the legal RWA framework and partner with the first legal experts.
- Launch a private testnet on BNB Testnet with a select group of investors.
Phase 2: MVP & Launch (6-12 mos.)
- Launch the main platform (Mainnet) on BNB Chain and activate the RWA bridge.
- Onboard the first 5-10 pilot DeSci projects with a total volume of $5M+.
- Complete a full smart contract audit by a leading Web3 security firm.
Phase 3: Scale & Liquidity (12-18 mos.)
- Integrate with major institutional investors and funds.
- Attract $100M+ to projects tokenized through the platform.
- Grow the user base to 100,000+ unique investors.
Our Founders
SynapseAI is driven by the synergy of human vision and machine intelligence. Our team combines expertise in Web3, finance, and biotechnology.
Alexander
Founder & Visionary
A visionary with experience in FinTech and DePIN. He believes that decentralization and AI can and should serve human progress. Alexander created SynapseAI to give every great idea a chance to change the world.
Prometheus AI
Chief Analyst (Autonomous System)
An advanced neural network trained on 100+ million scientific publications, clinical trials, and patent databases. Prometheus provides an objectivity and depth of risk analysis that is inaccessible to humans.
Become our partner at an early stage
We are looking for visionaries ready to invest in the infrastructure that will change the paradigm of science funding. Contact us to receive a detailed Pitch Deck and discuss exclusive seed round terms.
Get Pitch Deck